Intellia Therapeutics Head office building

Investors
& Media

Banner Menu

Press Releases

Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026

Read More

Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London

Read More

Upcoming
Events

More events are coming soon.

Stock Information

Minimum 15 minutes delayed. Source: LSEG